COMPANY PROFILE

Oncosoft

Explore full profile

AI-driven auto segmentation and workflow management for radiology, enhancing efficiency and accuracy in medical imaging

South KoreaFounded 2019Health Tech & Medtech

Valuation $50–100M Last recorded · 2024

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Oncosoft

Oncosoft operates in the healthcare sector, focusing on radiology departments that require advanced solutions for radiotherapy. The company leverages deep learning models to provide AI-driven automatic segmentation, which addresses the shortage of highly educated staff in hospitals. Oncosoft's cloud-based platform ensures secure and efficient data management, allowing for easy access and management of patient care schedules and various modalities. The business model is likely SaaS-based, offering tools like a contouring assistant for precise medical imaging. Revenue is generated through subscriptions or licensing of their software solutions to healthcare institutions. The target clients are hospitals and medical facilities that need to enhance their workflow efficiency and accuracy in radiology. Oncosoft's offerings are designed to save time and improve productivity, making it a valuable partner in the medical community.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: South Korea
Open positions: None listed
Dealroom signal: 19.3/100
Industry: Health
Sub-industry: Medical Devices, Health Platform
Sector: Health Tech & Medtech, Radiology, AI for medical imaging, Health It
Technology: Artificial Intelligence, Machine Learning, Deep Learning
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Sep 2024	$12M	$47M	Undisclosed	↗
LATE VC✓Equity / VC	Aug 2022	$2.5M	$10M	BNH Investment · HB Investment	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Oncosoft website traffic

Latest recorded traffic for Oncosoft is 830 monthly website visits, down 63.9% over the last three months.

Latest monthly visits830 3-month web change-63.9%

Monthly website visitsJul 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
FLFloyDeveloping AI to support radiologists in seeing diseases difficult to detect	Munich, Germany	Operational	60	$14M	$30M
COcontextflowNovel machine-learning based image analysis solution to help improve radiologists’ daily clinical workflows	Vienna, Austria	Acquired
MAMVision AIOffers solution for modern cancer radiation therapy treatment through innovative AI technology	Helsinki, Finland	Operational
KTKheiron Medical TechnologiesHelps radiologists detect breast cancer earlier using deep learning	London, United Kingdom	Acquired
PIPixylNeuroimaging AI for Improved Patient Care	La Tronche, France	Acquired
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
BRBrainscanAI-powered decision support for brain CT scan analysis	Gdynia, Poland	Operational
RARadioboticsAutomating routine tasks, alleviating the urgent need for specialized radiologists, whilst improving diagnostic quality	Copenhagen, Denmark	Acquired